The University of Chicago Header Logo

Connection

John Fung to Recurrence

This is a "connection" page, showing publications John Fung has written about Recurrence.
Connection Strength

0.341
  1. Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford). 2011 Sep; 13(9):651-5.
    View in: PubMed
    Score: 0.077
  2. Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation. Clin Transplant. 2010 Sep-Oct; 24(5):701-8.
    View in: PubMed
    Score: 0.072
  3. Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. Clin Transplant. 1995 Jun; 9(3 Pt 2):262-8.
    View in: PubMed
    Score: 0.025
  4. The successful use of telaprevir to treat hepatitis C recurrence after liver transplantation in an HIV co-infected patient. Transplantation. 2014 Jan 27; 97(2):e14-5.
    View in: PubMed
    Score: 0.023
  5. Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients. Liver Transpl. 2009 Nov; 15(11):1557-63.
    View in: PubMed
    Score: 0.017
  6. Impact of Orthoclone OKT3 on liver transplantation. Transplant Proc. 1987 Apr; 19(2 Suppl 1):37-44.
    View in: PubMed
    Score: 0.014
  7. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant. 2006 Dec; 6(12):2983-93.
    View in: PubMed
    Score: 0.014
  8. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
    View in: PubMed
    Score: 0.012
  9. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
    View in: PubMed
    Score: 0.010
  10. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin. Liver Transpl. 2001 Oct; 7(10):863-9.
    View in: PubMed
    Score: 0.010
  11. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation. 2001 Sep 15; 72(5):851-5.
    View in: PubMed
    Score: 0.010
  12. Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
    View in: PubMed
    Score: 0.010
  13. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999 Jul; 117(1):149-53.
    View in: PubMed
    Score: 0.008
  14. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998 Jan 15; 65(1):82-6.
    View in: PubMed
    Score: 0.008
  15. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
    View in: PubMed
    Score: 0.007
  16. Survival and quality of life after liver transplantation for acute alcoholic hepatitis. Liver Transpl Surg. 1997 May; 3(3):240-4.
    View in: PubMed
    Score: 0.007
  17. The patient with chronic hepatitis C. Liver Transpl Surg. 1996 Sep; 2(5 Suppl 1):73-8.
    View in: PubMed
    Score: 0.007
  18. Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc. 1995 Feb; 27(1):1193-4.
    View in: PubMed
    Score: 0.006
  19. FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats. Surgery. 1991 Aug; 110(2):357-63; discussion 363-4.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.